MannKind Corporation Announces FDA Approval of AFREZZA(R); A Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes

World News: . []

VALENCIA Calif June 27 2014 GLOBE NEWSWIRE -- LINK  Corporation NasdaqMNKD today announced that the US Food Drug Administration FDA has approved LINK  insulin human Inhalation Powder to LINK  glycemic control in adult LINK  s with ...

More news and information about MannKind Corporation

Published By:

Globe Newswire: 22:06 GMT Friday 27th June 2014

Published: .

Search for other references to "mannkind" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us